Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

RadNet Temettü

Temettü kriter kontrolleri 0/6

RadNet şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

n/a

Ödeme oranı

Sektör ortalama getirisi	1.6%
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Hisse başına kazanç	US$0.13
Temettü verim tahmini	n/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued

Nov 26

RadNet JV acquires Montclair Radiology's outpatient radiology assets

Oct 11

Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital

Oct 10

RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha

Aug 28

Here's Why RadNet (NASDAQ:RDNT) Has A Meaningful Debt Burden

Aug 12

RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance

Aug 09

RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return

Jul 01

Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

Jun 17

Is RadNet (NASDAQ:RDNT) A Risky Investment?

May 11

Estimating The Intrinsic Value Of RadNet, Inc. (NASDAQ:RDNT)

Apr 06

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: RDNT şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: RDNT şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

RadNet Piyasaya Karşı Temettü Getirisi

RDNT temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (RDNT)	n/a
Pazarın Alt %25'i (US)	1.4%
Pazarın En İyi %25'i (US)	4.3%
Sektör Ortalaması (Healthcare)	1.6%
Analist tahmini (RDNT) (3 yıla kadar)	n/a

Önemli Temettü: RDNT şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, RDNT şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: RDNT şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: RDNT herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

RadNet Temettü

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü güncellemeleri

Recent updates

RadNet: Secular Tailwinds Underpinned By AI Monetization Prospects

Unpleasant Surprises Could Be In Store For RadNet, Inc.'s (NASDAQ:RDNT) Shares

RadNet, Inc. Appoints Cornelis “Kees” Wesdorp as President and Chief Executive Officer of its Digital Health Segment, Effective October 1, 2024

RadNet: Growth In Operating Earnings Off Very Little Incremental Capital

RadNet (NASDAQ:RDNT) Seems To Use Debt Quite Sensibly

Returns On Capital At RadNet (NASDAQ:RDNT) Have Stalled

RadNet: Qualified Growth Route, Still Undervalued

Price target increased by 7.2% to US$57.17

Is There Now An Opportunity In RadNet, Inc. (NASDAQ:RDNT)?

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Now 23% overvalued after recent price rise

RadNet, Inc., Annual General Meeting, Jun 12, 2024

Price target increased by 7.0% to US$53.33

Are RadNet, Inc. (NASDAQ:RDNT) Investors Paying Above The Intrinsic Value?

Now 21% overvalued after recent price rise

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $200.2 million.

Consensus EPS estimates increase by 12%

RadNet, Inc.'s (NASDAQ:RDNT) 26% Price Boost Is Out Of Tune With Revenues

Price target increased by 12% to US$45.80

Now 21% overvalued after recent price rise

Full year 2023 earnings: EPS misses analyst expectations

Why RadNet, Inc. (NASDAQ:RDNT) Could Be Worth Watching

RadNet, Inc. Stock Price Is More Vigorous Than Its Valuation

Getting In Cheap On RadNet, Inc. (NASDAQ:RDNT) Might Be Difficult

Insider recently sold US$354k worth of stock

Insider notifies of intention to sell stock

RadNet, Inc. Launches a Pilot Inside Walmart of its New MammogramNow™ Offering

We Think RadNet (NASDAQ:RDNT) Can Stay On Top Of Its Debt

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

RadNet, Inc. Unveils DeepHealth, a Pioneering AI-Powered Health Informatics Portfolio

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

RadNet (NASDAQ:RDNT) Might Be Having Difficulty Using Its Capital Effectively

New major risk - Financial position

RadNet, Inc. Appoints Dr. Gregory Sorensen as Executive Vice President and Chief Science Officer

RadNet (NASDAQ:RDNT) Takes On Some Risk With Its Use Of Debt

Radnet, Inc. Revises Earnings Guidance for the Year 2023

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

RadNet, Inc. Announces Appointment of Executives

Consensus EPS estimates upgraded to US$0.10 loss

RadNet, Inc. has completed a Follow-on Equity Offering in the amount of $225.35625 million.

President & COO of Western Operations recently sold US$1.4m worth of stock

RadNet, Inc. Announces Ruth V. Wilson Did Not to Stand for Re-Election to the Board of Directors

President & COO of Western Operations exercised options to buy US$1.5m worth of stock.

RadNet, Inc., Annual General Meeting, Jun 07, 2023

Board Member recently sold US$138k worth of stock

RadNet, Inc. Revises Earnings Guidance for the Year 2023

Price target increased by 7.8% to US$34.50

We Think RadNet (NASDAQ:RDNT) Is Taking Some Risk With Its Debt

President & COO of Eastern Operations recently sold US$230k worth of stock

Insider recently sold US$443k worth of stock

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

RadNet (NASDAQ:RDNT) Will Want To Turn Around Its Return Trends

Radiology Imaging Associates Launches the Enhanced Breast Cancer Detection Program, Providing Women A New State-Of-The-Art Solution Powered by Artificial Intelligence

President & COO of Western Operations recently sold US$97k worth of stock

RadNet (NASDAQ:RDNT) Has A Somewhat Strained Balance Sheet

An Intrinsic Calculation For RadNet, Inc. (NASDAQ:RDNT) Suggests It's 41% Undervalued

Consensus forecasts updated

Third quarter 2022 earnings: EPS misses analyst expectations

RadNet, Inc. Provides Earnings Guidance for the Full Year of 2022

Investor sentiment deteriorated over the past week

RadNet, Inc. (NasdaqGM:RDNT) acquired 75% stake in Heart & Lung Imaging Limited.

RadNet JV acquires Montclair Radiology's outpatient radiology assets

Some Investors May Be Worried About RadNet's (NASDAQ:RDNT) Returns On Capital

Price target decreased to US$32.25

Investor sentiment improved over the past week

RadNet Presents With The Idiosyncratic Risk Premia To Deliver Risk-Adjusted Alpha

Investor sentiment improved over the past week

Here's Why RadNet (NASDAQ:RDNT) Has A Meaningful Debt Burden

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

RadNet, Inc. Updates Earnings Guidance for 2022

RadNet Non-GAAP EPS of $0.15 beats by $0.06, revenue of $354.1M beats by $5.16M;reaffirms FY guidance

RadNet (NASDAQ:RDNT) Is Reinvesting At Lower Rates Of Return

Is It Time To Consider Buying RadNet, Inc. (NASDAQ:RDNT)?

President & COO of Western Operations recently sold US$205k worth of stock

RadNet, Inc. Announces That It Has Received FDA Clearances for Its DeepHeatlh Saige-DX™ Mammography and Quantib® Prostate 2.0 MRI Artificial Intelligence ("Ai") Algorithms